Rain Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Rain Oncology has a total shareholder equity of $67.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $82.1M and $14.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$77.34m |
Equity | US$67.52m |
Total liabilities | US$14.54m |
Total assets | US$82.06m |
Recent financial health updates
Is Rain Oncology (NASDAQ:RAIN) In A Good Position To Invest In Growth?
Feb 23We Think Rain Therapeutics (NASDAQ:RAIN) Needs To Drive Business Growth Carefully
Nov 08Here's Why We're Watching Rain Therapeutics' (NASDAQ:RAIN) Cash Burn Situation
Aug 03We're Not Very Worried About Rain Therapeutics' (NASDAQ:RAIN) Cash Burn Rate
Apr 17Recent updates
Is Rain Oncology (NASDAQ:RAIN) In A Good Position To Invest In Growth?
Feb 23We Think Rain Therapeutics (NASDAQ:RAIN) Needs To Drive Business Growth Carefully
Nov 08Rain Therapeutics GAAP EPS of -$0.66 in-line
Aug 04Here's Why We're Watching Rain Therapeutics' (NASDAQ:RAIN) Cash Burn Situation
Aug 03We're Not Very Worried About Rain Therapeutics' (NASDAQ:RAIN) Cash Burn Rate
Apr 17We Think Rain Therapeutics (NASDAQ:RAIN) Can Afford To Drive Business Growth
Dec 25We're Hopeful That Rain Therapeutics (NASDAQ:RAIN) Will Use Its Cash Wisely
Sep 21Financial Position Analysis
Short Term Liabilities: RAIN's short term assets ($80.8M) exceed its short term liabilities ($14.5M).
Long Term Liabilities: RAIN's short term assets ($80.8M) exceed its long term liabilities ($64.0K).
Debt to Equity History and Analysis
Debt Level: RAIN is debt free.
Reducing Debt: RAIN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RAIN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: RAIN has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 42.8% each year.